Semaglutide vs Tirzepatide: Difference Between These Weight Loss Medications

Semaglutide and tirzepatide are two prescription medicines doctors use for type 2 diabetes and, for some patients, weight management. They work in similar ways, but they are not the same. This guide explains how each one works, where they differ, and how to talk to a doctor about whether either fits you..

What are Semaglutide and Tirzepatide?

Before weighing semaglutide vs tirzepatide, start with what each one is. Both copy incretins, the gut hormones your body releases after a meal to help manage appetite and control blood sugar. In the Philippines, both are registered as prescription drugs, which you can confirm on the FDA Philippines verification portal.

Semaglutide: A GLP-1 Receptor Agonist

As a GLP-1 receptor agonist, semaglutide acts like glucagon-like peptide-1 (GLP-1), a natural hormone that signals fullness and helps the pancreas release insulin when blood sugar rises. It belongs to a medicine class called incretin mimetics, the same class as tirzepatide. In the Philippines, semaglutide is registered for type 2 diabetes (as an injection or a tablet), for weight management in adults and teens 12 and older, and, in adults with type 2 diabetes and heart disease, to lower the risk of heart attack and stroke.

In the US, it is also approved to lower heart risk in adults with obesity and to slow kidney disease in some adults with type 2 diabetes.

Tirzepatide: A Dual GIP and GLP-1 Receptor Agonist

Unlike semaglutide, tirzepatide acts on two hormone receptors. Besides GLP-1, it activates the receptor for glucose-dependent insulinotropic polypeptide (GIP), another gut hormone involved in insulin release. In the Philippines, tirzepatide is registered for type 2 diabetes and for weight management in adults.

In the US, it is also approved for obstructive sleep apnea in adults with obesity. It is given as an injection under the skin.”

How These Gut Hormones Work in Your Body

Every time you eat, your gut sends hormone signals to your brain and pancreas. Semaglutide and tirzepatide strengthen these signals in three main ways.

Appetite and Food Intake

Each medicine acts on appetite centers in the brain, and targets your hunger so you feel full sooner and stay full longer. This tends to lower food intake without a constant fight against insatiation.

Some people also talk about “food noise,” the constant background thoughts about eating. Researchers are still studying how these medicines affect it, and whether either one quiets food noise more than the other is not settled.

Gastric Emptying

These medicines also slow gastric emptying, meaning food leaves your stomach more slowly. Because sugar from a meal enters the blood more gradually, slower emptying also helps keep blood glucose levels steadier after you eat.

Insulin Release and Blood Sugar Levels

After a meal, these medicines prompt the pancreas to release insulin when blood sugar is high. This boost in insulin secretion depends on glucose, so the effect is strongest when blood sugar levels climb.

Read this related article on GLP-1 drugs for weight management to learn how this class of medicines works.

Semaglutide vs Tirzepatide: Key Differences

The two medicines share a lot, including better glycemic control in type 2 diabetes, but they are not interchangeable. Here is where they differ most.

Single Action vs Dual Action

Animal studies link tirzepatide’s GIP side to better insulin sensitivity, which matters for people with insulin resistance. Human data on how much this dual action adds is still limited.

Weight Reduction in Clinical Trials

Each medicine has led to significant weight loss in clinical trials when paired with diet and exercise. In 2025, the first head-to-head trial in adults with obesity but without diabetes, the SURMOUNT-5 study in the New England Journal of Medicine, found greater weight loss with tirzepatide.

That trial was open-label and funded by the maker of tirzepatide, so doctors read it alongside other evidence. Average weight loss in a study also does not predict your own result, and not everyone sees significant weight loss on either medicine.

Heart Disease Risk Reduction

Semaglutide has a US approval to lower the risk of heart attack, stroke, and cardiovascular death in adults with established cardiovascular disease and obesity or overweight. It was the first weight management medicine to receive that approval, according to the US Food and Drug Administration.

NOTE: In the Philippines, semaglutide’s heart approval covers adults with type 2 diabetes and established heart disease. The US approval for adults with obesity is not on the Philippine label, so ask your doctor whether it applies to you.

Consult a cardiologist on NowServing if you have heart disease or it runs in your family.

Cost Difference

Tirzepatide generally costs more than semaglutide in the Philippines. In online pharmacy listings in October 2026, a lowest-strength semaglutide pen cost about PHP 7,600 to PHP 9,900, and a lowest-strength tirzepatide pen about PHP 10,800 to PHP 12,600. Higher strengths cost more.

These are estimates only. Prices change often and vary by pharmacy, so ask your pharmacist for a current price. Your doctor decides which medicine and strength fits you, if any.

NOTE: Buy weight loss medicines only from an FDA-licensed pharmacy, with a valid prescription. Unregistered tirzepatide products sold online carry no assurance of quality, safety, or efficacy, according to an FDA Philippines public health warning.

Blood Sugar Control in Type 2 Diabetes

Type 2 diabetes is the most common form of diabetes mellitus, in which the body does not use insulin well. Semaglutide and tirzepatide both improve glycemic control by boosting insulin secretion when blood glucose levels rise after meals.

Insulin resistance often comes with excess body weight, and over time it pushes blood sugar levels up. Lowering body weight can improve insulin sensitivity, which is why weight management and blood sugar control often share one treatment plan.

On their own, these medicines seldom cause low blood sugar. The risk rises when they are taken with insulin or some other diabetes medications, so your doctor may adjust them. Know the signs of low blood sugar, such as shakiness, sweating, and dizziness, and tell your doctor if you notice them.

Consult an endocrinologist on NowServing for diabetes-related doctor consultations.

Who Qualifies for Semaglutide and Tirzepatide

Weight loss medications like semaglutide and tirzepatide are prescription-only. That means, your doctor will decide whether you are eligible to use these GLP-1 drugs. In the Philippines, doctors use the Asia-Pacific body mass index cutoffs. A BMI of 23 to 24.9 is considered overweight, and 25 and above is considered obesity. That’s just one of the factors that doctors consider.

A doctor’s review also covers:

• Medical history: Past and current conditions, such as high blood pressure, cardiovascular disease, or pancreatitis.
• Family history: Thyroid cancer, diabetes, and heart disease in close relatives.
• Current medicines: Diabetes medications, supplements, and anything that affects digestion.
• Lab results: Blood sugar, cholesterol, and kidney function tests.
• Pregnancy plans: Whether you are pregnant, breastfeeding, or planning to conceive.

Not everyone qualifies, and wanting to lose weight alone does not make someone a candidate for a weight loss drug. Because obesity is a chronic disease, treatment often continues for the long term, and your doctor decides how long it lasts.

Check out all the factors that doctors consider before prescribing weight loss medications.

Why Lifestyle Changes Still Matter

These weight loss medications are meant to work alongside a reduced-calorie diet and more physical activity, never in place of them. Lasting weight reduction depends on the habits you build, which also protect your overall health over the long term.

A few Filipino-friendly habits make a good start:

• Pinggang Pinoy plate: Fill half your plate with vegetables and fruits, about a third with rice or other grains, and the rest with fish, lean meat, or beans.
• Carinderia swaps: Choose tinola, inihaw, or pinakbet over two fried dishes, and take one scoop of rice.
• Daily movement: Walking after dinner or taking the stairs at work adds up.

Discover how to start a diet plan for weight loss or read this article for Filipino meals and correct portions for weight loss based on DOST-FNRI Pinggang Pinoy.

Side Effects and Other Precautions for Using Semaglutide and Tirzepatide

Like all medications, users must be aware of certain precautions before using GLP-drugs. Side effects are common in the first weeks, mostly stomach-related. These side effects tend to be stronger at higher doses. That is why doctors start low and raise the amount slowly, giving your body time to adjust.

The common side effects include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Stomach discomfort or bloating

Contact your doctor if you have any concerns about these side effects.

Other Precautions

Follow your doctor’s instructions exactly, and ask before changing anything, including adding another weight loss medicine.

How to Book a Weight Management Consultation on NowServing

Weight loss medications like semaglutide and tirzepatide are prescription-only drugs. Only a doctor can decide whether either medicine fits you. You can book a weight management consult on NowServing, online or in person.

Here’s how:

1. Open the NowServing app and find a weight loss management doctor (Read this guide to discover specialists for weight loss)
2. Pick a doctor and select online or in-person consultation
3. Fill-up the consultation form and schedule the date for your appointment
4. Wait for doctor’s confirmation

Coverage for weight management consults varies across HMO and commercial insurance plans. Most HMO plans do not cover weight loss medicines, though many cover the doctor consult.

Read this related article on what to expect in a weight management consultation.

FAQs About Semaglutide vs Tirzepatide

Is tirzepatide stronger than semaglutide?

In the first head-to-head trial, tirzepatide led to greater weight loss on average. Still, average weight loss hides a wide range of results, and no single weight loss drug suits every patient. Your doctor weighs side effects and your health conditions together.

Can I switch from semaglutide to tirzepatide?

Only your doctor can decide that, after reviewing your response so far and any side effects. Never start, stop, or switch either medicine on your own.

Do I need a prescription for semaglutide or tirzepatide?

Yes. Both are prescription-only medicines. Weight loss medicines sold without a prescription may be unregistered or unsafe.

Which doctor should I see about semaglutide vs tirzepatide?

There are many doctors you can visit for weight loss management. You can visit selected specialists for prescription medications for weight loss, like endocrinologists, obesity medicine specialists, and internists commonly handle medical weight management.

Conclusion

Both GLP-1 receptor agonists may target the same goal for weight loss, however, semaglutide and tirzepatide still have differences. Semaglutide is single action while tirzepatide provides dual action. Furthermore, each is tested and approved for different uses based on clinical trials and FDA. Still, using them correctly through the guidance of your doctor can help you reach your goal, weight management.

Ready to manage your weight today? You can start with an online assessment via NowExpress. Medical experts review your assessment and guide you along the way.

Visit NowExpress to start online assessment and doctor-guided weight loss management.

Book a weight management consultation on NowServing.